Georgia
Tuberculosis profile
| High MDR-TB burden |
Population  2012 4.4 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.2 (0.16–0.24) 4.5 (3.7–5.5)
Mortality (HIV+TB only) <0.01 (<0.01–0.01) 0.2 (0.17–0.24)
Prevalence  (includes HIV+TB) 6.9 (2.9–13) 158 (67–288)
Incidence  (includes HIV+TB) 5 (4.5–5.6) 116 (103–130)
Incidence (HIV+TB only) 0.05 (0.045–0.056) 1.2 (1–1.3)
Case detection, all forms (%) 78 (70–88)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 1 648 (44) Relapse 161 (13)
Smear-negative 1 139 (30) Treatment after failure 103 (9)
Smear-unknown / not done 47 (1) Treatment after default 95 (8)
Extrapulmonary 944 (25) Other 836 (70)
Other 0 (0)      
Total new 3 778   Total retreatment 1 195  
           
Other (history unknown) 1        
Total new and relapse 3 939   Total cases notified 4 974  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 3.0 2.6 1.4
Age < 15 9 19 187
Laboratories 2012
Smear (per 100 000 population) 0.3
Culture (per 5 million population) 2.3
Drug susceptibility testing (per 5 million population) 1.1
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 76   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 87  
Retreatment 61  
TB/HIV 2012 Number (%)
TB patients with known HIV status 1 881 (38)
HIV-positive TB patients 33 (2)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 26 (79)
HIV-positive TB patients on antiretroviral therapy (ART) 26 (79)
HIV-positive people screened for TB 519  
HIV-positive people provided with IPT 97  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 9.2 (7.9–11) 31 (27–35)
MDR-TB cases among notified pulmonary
TB cases
260 (220–300) 370 (330–420)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 1 931 (84%) 541 (45%) 2 472
Laboratory-confirmed MDR-TB cases 177 169 346
Patients started on MDR-TB treatment     665
Financing TB control 2013
National TB programme budget (US$ millions) 10
% Funded domestically 63%
% Funded internationally 37%
% Unfunded 0%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data